Microbicides Research, Development, and Introduction
Clinical trials of vaginal microbicide have been tested recently in South Africa to determine efficacy of reduction of HIV infection. Microbicide research, development, and introduction activities which could potentially be supported through this APS mechanism are expected to contribute substantially to the Principles of the Global Health Initiative (GHI), particularly in promoting research and innovation; implementing a woman- and girl-centered approach; strengthening and leveraging inputs from multilateral organizations, global health partnerships, and the private sector; and encouraging country ownership and leadership. Potential activities could also contribute significantly to strengthening the health system building blocks related to commodities and procurement, service delivery, and leadership and governance. It is expected that gender analyses and other gender considerations will continue to inform the design and implementation of activities implemented as part of the AgencyÂ’s microbicide program. All awards will also be subject to USAID environmental requirements, including completion of an initial environmental examination. See attached APS for full Funding Opportunity description.
General information about this opportunity
Last Known Status
Active
Program Number
APS-OAA-12-000007
Federal Agency/Office
Agency: Agency for International Development
Type(s) of Assistance Offered
Cooperative Agreement
Other Categories
Clinical trials of vaginal microbicide have been tested recently in South Africa to determine efficacy of reduction of HIV infection. Microbicide research, development, and introduction activities which could potentially be supported through this APS mechanism are expected to contribute substantially to the Principles of the Global Health Initiative (GHI), particularly in promoting research and innovation; implementing a woman- and girl-centered approach; strengthening and leveraging inputs from multilateral organizations, global health partnerships, and the private sector; and encouraging country ownership and leadership. Potential activities could also contribute significantly to strengthening the health system building blocks related to commodities and procurement, service delivery, and leadership and governance. It is expected that gender analyses and other gender considerations will continue to inform the design and implementation of activities implemented as part of the AgencyÂ’s microbicide program. All awards will also be subject to USAID environmental requirements, including completion of an initial environmental examination. This APS is intended to support the creative research and other innovative activities that are now essential to advance potential microbicides toward regulatory approval and then to successfully introduce them into delivery programs. Attaining these objectives will fill a critical gap in the options women and girls currently have to protect themselves from HIV infection.
Who is eligible to apply/benefit from this assistance?
Applicant Eligibility
Elibility requirements included in attached document.
What is the process for applying and being award this assistance?
Application Procedure
TBD
Other Assistance Considerations
Formula and Matching Requirements
This program does not have cost sharing or matching requirements.
Who do I contact about this opportunity?
Headquarters Office
Kathleen Bumpass
Contracts Specialist
Phone 202-567-5008
E-mail Address
kbumpass@usaid.gov
Financial Information
Obligations
$0.00
Range and Average of Financial Assistance
Awards range from $100,000.00 to $2,250,000.00
